Your browser doesn't support javascript.
loading
Cell-based noninvasive prenatal testing (cbNIPT) detects pathogenic copy number variations.
Hatt, Lotte; Singh, Ripudaman; Christensen, Rikke; Ravn, Katarina; Christensen, Inga B; Jeppesen, Line Dahl; Nicolaisen, Bolette Hestbek; Kølvraa, Mathias; Schelde, Palle; Andreassen, Lotte; Farlie, Richard; Uldbjerg, Niels; Vogel, Ida.
Afiliação
  • Hatt L; ARCEDI Biotech ApS Vejle Denmark.
  • Singh R; ARCEDI Biotech ApS Vejle Denmark.
  • Christensen R; Center for Fetal Diagnostics Department of Clinical Genetics Aarhus University Hospital Aarhus Denmark.
  • Ravn K; ARCEDI Biotech ApS Vejle Denmark.
  • Christensen IB; ARCEDI Biotech ApS Vejle Denmark.
  • Jeppesen LD; ARCEDI Biotech ApS Vejle Denmark.
  • Nicolaisen BH; ARCEDI Biotech ApS Vejle Denmark.
  • Kølvraa M; ARCEDI Biotech ApS Vejle Denmark.
  • Schelde P; ARCEDI Biotech ApS Vejle Denmark.
  • Andreassen L; Center for Fetal Diagnostics Department of Clinical Genetics Aarhus University Hospital Aarhus Denmark.
  • Farlie R; Department of Women's Disease and Birth Viborg Hospital Viborg Denmark.
  • Uldbjerg N; Department of Women's Disease and Birth Aarhus University Hospital Aarhus Denmark.
  • Vogel I; Department of Clinical Medicine Aarhus University Aarhus Denmark.
Clin Case Rep ; 8(12): 2561-2567, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33363780
ABSTRACT
In two cases, cell-based noninvasive prenatal testing (cbNIPT) detected pathogenic copy number variations (CNVs) in the fetal genome. cbNIPT may potentially be an improved noninvasive alternative for the detection of smaller CNVs.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2020 Tipo de documento: Article